In conclusion, our results provide evidence that Derlin-1 is overexpressed in bladder cancer and that high expression levels of Derlin-1 correlate with tumor grade, metastasis, and poor overall survival. The gene discussed is DERL1; the disease is urinary bladder carcinoma.